Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 4;8(8):275.
doi: 10.3390/antiox8080275.

p-Coumaric Acid as An Active Ingredient in Cosmetics: A Review Focusing on its Antimelanogenic Effects

Affiliations
Review

p-Coumaric Acid as An Active Ingredient in Cosmetics: A Review Focusing on its Antimelanogenic Effects

Yong Chool Boo. Antioxidants (Basel). .

Abstract

Controlling unwanted hyperpigmentation is a major challenge in dermatology and cosmetology, and safe and efficacious antimelanogenic agents are deemed useful for this purpose. p-Coumaric acid is a natural metabolite contained in many edible plants, and its antioxidant activities in reducing oxidative stress and inflammatory reactions have been demonstrated in various experimental models. p-Coumaric acid has the optimal structure to be a competitive inhibitor of tyrosinase that catalyzes key reactions in the melanin biosynthetic pathway. Experimental evidence supports this notion as it was found to be a more potent inhibitor of tyrosinase, especially toward human enzymes, than other well-known tyrosinase inhibitors such as arbutin and kojic acid. p-Coumaric acid inhibited melanin synthesis in murine melanoma cells, human epidermal melanocytes, and reconstituted three-dimensional human skin models. Ex-vivo skin permeation experiments and in-vivo efficacy tests for p-coumaric acid confirmed its efficient transdermal delivery and functional efficacy in reducing erythema development and skin pigmentation due to ultraviolet radiation exposure. Human studies further supported its effectiveness in hypopigmentation and depigmentation. These findings suggest that p-coumaric acid has good potential to be used as a skin-lightening active ingredient in cosmetics. Future studies are needed to extensively examine its safety and efficacy and to develop an optimized cosmetic formulation for the best performance in skin lightening.

Keywords: 4-hydroxycinnamic acid; UV; antioxidant; cosmetics; inflammation; melanin; oxidative stress; p-coumaric acid; phytochemical; pigmentation; skin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
p-Coumaric acid can attenuate skin hyperpigmentation through multiple mechanisms. UV and other pathophysiological conditions stimulate the production of reactive oxygen species (ROS) and multiple signaling pathways leading to enhanced gene expression of tyrosinase and increased melanin synthesis. The melanin can absorb ultraviolet (UV) radiation and alleviate oxidative stress and inflammatory reactions caused by UV radiation, but the melanin deposition may cause skin pigmentation disorders. p-Coumaric acid has a chemical structure similar to L-tyrosine and inhibits the activity of tyrosinase, which catalyzes the oxidation of L-tyrosine and/or L-DOPA to L-DOPA quinone in the melanin biosynthetic pathway. Due to its UV absorption and antioxidant action, p-coumaric acid can inhibit the signaling pathways linked to gene expression of tyrosinase and inflammatory mediators. p-Coumaric acid can also reduce the stimulatory effects of hormones and L-tyrosine on the gene expression of tyrosinase. Thus, it is proposed that p-coumaric acid has advantageous biochemical properties suitable for use as a skin-lightening active ingredient in cosmetics.

References

    1. Maresca V., Flori E., Picardo M. Skin phototype: A new perspective. Pigment Cell Melanoma Res. 2015;28:378–389. doi: 10.1111/pcmr.12365. - DOI - PubMed
    1. Nasti T.H., Timares L. MC1R, eumelanin and pheomelanin: Their role in determining the susceptibility to skin cancer. Photochem. Photobiol. 2015;91:188–200. doi: 10.1111/php.12335. - DOI - PMC - PubMed
    1. Slominski R.M., Zmijewski M.A., Slominski A.T. The role of melanin pigment in melanoma. Exp. Derm. 2015;24:258–259. doi: 10.1111/exd.12618. - DOI - PMC - PubMed
    1. Fistarol S.K., Itin P.H. Disorders of pigmentation. J. Dtsch. Derm. Ges. 2010;8:187–201. doi: 10.1111/j.1610-0387.2009.07137.x. - DOI - PubMed
    1. Davis E.C., Callender V.D. Postinflammatory hyperpigmentation: A review of the epidemiology, clinical features, and treatment options in skin of color. J. Clin. Aesthet. Derm. 2010;3:20–31. - PMC - PubMed

LinkOut - more resources